Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapy.
作者信息
Asdourian Maria S, Shah Nishi, Jacoby Ted V, Thompson Leah L, Otto Tracey, Semenov Yevgeniy R, Reynolds Kerry L, Chen Steven T
机构信息
Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Virginia Commonwealth University School of Medicine, Richmond, Virginia.
出版信息
J Am Acad Dermatol. 2023 Jan;88(1):246-249. doi: 10.1016/j.jaad.2022.05.015. Epub 2022 May 13.
Abstract
摘要
相似文献
1
Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapy.评估免疫检查点抑制剂治疗后皮肤和非皮肤免疫相关不良事件的共现模式。
J Am Acad Dermatol. 2023 Jan;88(1):246-249. doi: 10.1016/j.jaad.2022.05.015. Epub 2022 May 13.
2
Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy.非皮肤免疫相关不良事件可预测免疫检查点抑制剂治疗后出现皮肤毒性的患者的总生存期和无进展生存期。
J Am Acad Dermatol. 2023 Jun;88(6):1368-1370. doi: 10.1016/j.jaad.2022.12.049. Epub 2023 Feb 2.
3
Histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitors.皮肤免疫相关不良事件的组织学亚型可预测接受免疫检查点抑制剂治疗患者的总生存期。
J Am Acad Dermatol. 2022 Sep;87(3):651-653. doi: 10.1016/j.jaad.2021.11.050. Epub 2021 Dec 4.
4
Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer.晚期癌症患者的皮肤和非皮肤免疫相关不良事件模式。
JAMA Dermatol. 2021 May 1;157(5):577-582. doi: 10.1001/jamadermatol.2021.0326.
5
Immune checkpoint inhibitor-related dermatologic adverse events.免疫检查点抑制剂相关的皮肤不良反应。
J Am Acad Dermatol. 2020 Nov;83(5):1255-1268. doi: 10.1016/j.jaad.2020.03.132. Epub 2020 May 23.
6
Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade.免疫检查点阻断后癌症患者出现多种皮肤免疫相关不良事件的情况。
J Am Acad Dermatol. 2023 Feb;88(2):485-487. doi: 10.1016/j.jaad.2022.06.030. Epub 2022 Jun 20.
7
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study.免疫检查点抑制剂引起的多器官免疫相关不良事件及其下游影响：一项回顾性多队列研究。
Lancet Oncol. 2024 Aug;25(8):1053-1069. doi: 10.1016/S1470-2045(24)00278-X. Epub 2024 Jul 15.
8
The effect of baseline eczema or psoriasis on the morphology of cutaneous immune-related adverse events due to immune checkpoint inhibitor therapy.基线湿疹或银屑病对免疫检查点抑制剂治疗引起的皮肤免疫相关不良事件形态学的影响。
J Am Acad Dermatol. 2023 May;88(5):1198-1200. doi: 10.1016/j.jaad.2023.01.002. Epub 2023 Jan 9.
9
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.晚期黑色素瘤患者接受免疫检查点抑制剂治疗期间血清乳酸脱氢酶与皮肤免疫相关不良事件的关联
J Am Acad Dermatol. 2022 Nov;87(5):1147-1149. doi: 10.1016/j.jaad.2022.02.024. Epub 2022 Feb 19.
10
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma.肿瘤浸润淋巴细胞作为晚期黑色素瘤患者免疫检查点阻断后皮肤免疫相关不良事件的预测生物标志物。
J Am Acad Dermatol. 2023 Jul;89(1):140-142. doi: 10.1016/j.jaad.2023.01.040. Epub 2023 Feb 15.
引用本文的文献
1
Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort study.皮肤免疫相关不良事件形态与全身免疫调节/免疫抑制治疗之间的关联：一项大型回顾性队列研究。
J Am Acad Dermatol. 2024 Jun;90(6):1268-1271. doi: 10.1016/j.jaad.2024.01.070. Epub 2024 Feb 9.
本文引用的文献
1
Histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitors.皮肤免疫相关不良事件的组织学亚型可预测接受免疫检查点抑制剂治疗患者的总生存期。
J Am Acad Dermatol. 2022 Sep;87(3):651-653. doi: 10.1016/j.jaad.2021.11.050. Epub 2021 Dec 4.
2
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy.免疫检查点抑制剂在伴有既往银屑病患者中的安全性和疗效。
J Immunother Cancer. 2021 Oct;9(10). doi: 10.1136/jitc-2021-003066.
3
Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer.晚期癌症患者的皮肤和非皮肤免疫相关不良事件模式。
JAMA Dermatol. 2021 May 1;157(5):577-582. doi: 10.1001/jamadermatol.2021.0326.
4
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer.与免疫检查点抑制剂治疗非小细胞肺癌相关的多系统免疫相关不良事件。
JAMA Oncol. 2020 Dec 1;6(12):1952-1956. doi: 10.1001/jamaoncol.2020.5012.
5
Dermatologic Reactions to Immune Checkpoint Inhibitors : Skin Toxicities and Immunotherapy.免疫检查点抑制剂的皮肤不良反应：皮肤毒性与免疫治疗
Am J Clin Dermatol. 2018 Jun;19(3):345-361. doi: 10.1007/s40257-017-0336-3.
Zotero 插件